VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SIGISelective Insurance Group, Inc.
$96.30$5.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksSIGIFinancials

Selective Insurance Group, Inc. (SIGI) Financials

30Y historyFree accessUpdated daily

Revenue growth has decelerated to 5.7% in 2026Q1, though the firm maintains underwriting discipline with a 89.9% combined ratio despite the 2024Q2 outlier loss event of 106.7%.

SIGI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue5.41B5.34B4.86B4.23B3.56B3.38B2.92B2.85B2.59B2.47B2.28B2.13B2.03B1.9B1.73B1.6B1.56B1.51B1.59B1.85B1.81B1.67B1.55B1.34B1.16B1.04B986.22M974.77M837.33M794.18M804.8M
Revenue Growth %8.61%9.78%14.87%18.95%5.3%15.63%2.66%10.07%4.7%8.13%7.15%4.77%6.89%9.78%8.55%2.1%3.34%-4.78%-13.88%2.12%8.19%7.56%16.37%15.33%11.18%5.57%1.17%16.41%5.43%-1.32%-4.09%
Medical Costs & Claims3.21B3.16B4.54B3.71B3.22B2.82B2.56B2.45B2.32B2.15B2.01B1.85B1.78B1.7B1.65B1.54B1.44B1.43B1.5B1.5B1.44B1.34B1.28B1.16B1.02B933.78M875.61M853.64M0679.14M715M
Medical Cost Ratio %59.31%59.17%93.39%87.76%90.44%83.35%87.71%85.91%89.88%86.94%87.84%86.7%87.57%89.39%94.98%96.49%91.91%94.41%94.17%81.05%79.56%80.41%82.35%86.87%88.3%89.69%88.78%87.57%0%85.51%88.84%
Gross Profit2.2B2.18B321.3M518.07M340.26M562.78M359.24M400.96M261.59M322.58M277.75M283.52M252.89M202.03M86.97M56.08M126.65M84.69M92.69M349.79M369.55M327.39M274.19M175.32M135.47M107.4M110.61M121.13M837.33M115.05M89.8M
Gross Margin %40.69%40.86%6.61%12.24%9.56%16.65%12.29%14.09%10.12%13.06%12.16%13.3%12.43%10.61%5.02%3.51%8.09%5.59%5.83%18.95%20.44%19.59%17.65%13.13%11.7%10.31%11.22%12.43%100%14.49%11.16%
Gross Profit Growth %-578.63%-37.98%52.26%-39.54%56.66%-10.4%53.28%-18.91%16.14%-2.03%12.11%25.18%132.3%55.07%-55.72%49.55%-8.63%-73.5%-5.34%12.88%19.4%56.39%29.42%26.14%-2.91%-8.68%-85.53%627.82%28.11%-85.44%
Operating Expenses1.65B1.59B63.26M59.66M60.08M57.47M56.25M64.57M49.87M60.61M57.8M50.82M55.76M58.22M49.33M44.68M42.5M45.5M52.53M157.03M149.03M124.6M117.12M108.4M103.96M-641.36M85.78M57.72M837.33M-456.64M-491.5M
OpEx / Revenue %30.56%29.81%1.3%1.41%1.69%1.7%1.92%2.27%1.93%2.45%2.53%2.38%2.74%3.06%2.84%2.8%2.72%3.01%3.3%8.51%8.24%7.46%7.54%8.12%8.98%-61.6%8.7%5.92%100%-57.5%-61.07%
Depreciation & Amortization269.07M32.67M34.8M30.04M42.34M55.11M59.35M55.2M44.87M52.1M61.67M59.69M45.35M43.46M38.69M34.65M31.77M28.59M28.55M29.14M25.68M21.38M24.52M16.2M11.95M15.25M15.25M13.04M9.3M8.1M6M
Combined Ratio %89.87%88.98%94.69%89.17%92.13%85.05%89.63%88.18%91.81%89.39%90.37%89.08%90.31%92.45%97.83%99.29%94.62%97.41%97.47%89.56%87.8%87.86%89.89%94.99%97.28%28.09%97.48%93.5%100%28.02%27.77%
Operating Income535.02M589.6M258.03M458.41M280.19M505.31M302.99M336.39M211.72M261.97M219.96M232.69M197.13M143.8M37.63M11.4M84.15M39.19M40.17M192.76M220.51M202.78M157.07M66.92M31.51M748.75M24.83M63.4M0571.68M581.3M
Operating Margin %9.89%11.05%5.31%10.83%7.87%14.95%10.37%11.82%8.19%10.61%9.63%10.92%9.69%7.55%2.17%0.71%5.38%2.59%2.53%10.44%12.2%12.14%10.11%5.01%2.72%71.91%2.52%6.5%0%71.98%72.23%
Operating Income Growth %-128.5%-43.71%63.61%-44.55%66.78%-9.93%58.88%-19.18%19.1%-5.47%18.04%37.09%282.1%230.13%-86.45%114.74%-2.44%-79.16%-12.59%8.74%29.1%134.71%112.38%-95.79%2916.01%-60.84%--100%-1.65%-4.3%
EBITDA817.29M622.27M292.83M488.45M322.52M560.42M362.34M391.6M256.6M314.07M281.63M292.38M242.48M187.26M76.33M46.05M115.92M67.78M68.72M221.9M246.19M224.16M181.59M83.12M43.46M764M40.07M76.45M82.41M579.78M587.3M
EBITDA Margin %15.1%11.66%6.02%11.54%9.06%16.58%12.4%13.76%9.92%12.72%12.33%13.71%11.92%9.84%4.4%2.88%7.41%4.48%4.32%12.02%13.62%13.41%11.69%6.23%3.75%73.38%4.06%7.84%9.84%73%72.97%
Interest Expense52.91M49.32M28.88M28.8M28.85M29.16M30.84M33.67M24.42M24.35M22.77M22.43M23.06M26.36M18.87M18.26M18.62M19.39M20.51M23.8M21.41M17.58M15.47M17.15M15.09M14.53M13.74M9.46M9.41M9.6M9.2M
Non-Operating Income-32.91M-49.32M-28.88M-28.8M-28.85M-29.16M-30.84M-33.67M-24.42M-24.35M-22.77M-22.43M-23.06M-26.36M-18.87M-18.26M-18.62M-19.39M-20.51M-23.8M-21.41M-17.58M-33.38M-38.21M-36.49M734.23M-13.74M-9.46M-73.11M562.08M572.1M
Pretax Income574.92M589.6M258.03M458.41M280.19M505.31M302.99M336.39M211.72M261.97M219.96M232.69M197.13M143.8M37.63M11.4M84.15M39.19M40.17M192.76M220.51M202.78M174.98M87.98M52.91M21.49M24.83M63.4M63.7M91M69.1M
Pretax Margin %10.63%11.05%5.31%10.83%7.87%14.95%10.37%11.82%8.19%10.61%9.63%10.92%9.69%7.55%2.17%0.71%5.38%2.59%2.53%10.44%12.2%12.14%11.26%6.59%4.57%2.06%2.52%6.5%7.61%11.46%8.59%
Income Tax120.73M123.2M51.02M93.17M55.3M101.47M56.63M64.77M32.78M93.14M61.46M66.83M55.3M36.39M-328K-11.28M13.4M-5.47M-3.93M46.26M56.94M55.33M46.34M21.64M10.77M-2.62M-1.86M9.69M10.13M21.4M13.5M
Effective Tax Rate %21%20.9%19.77%20.33%19.74%20.08%18.69%19.25%15.48%35.55%27.94%28.72%28.05%25.3%-0.87%-98.97%15.93%-13.96%-9.79%24%25.82%27.29%26.48%24.59%20.35%-12.19%-7.49%15.28%15.91%23.52%19.54%
Net Income454.18M466.41M207.01M365.24M224.89M403.84M246.35M271.62M178.94M168.83M158.5M165.86M141.83M106.42M37.96M22.03M66.97M36.4M43.76M146.5M163.57M148.49M128.64M66.34M41.97M25.69M26.54M53.72M53.57M69.6M55.6M
Net Margin %8.39%8.74%4.26%8.63%6.32%11.95%8.43%9.54%6.92%6.84%6.94%7.78%6.97%5.59%2.19%1.38%4.28%2.4%2.75%7.93%9.05%8.89%8.28%4.97%3.63%2.47%2.69%5.51%6.4%8.76%6.91%
Net Income Growth %93.77%125.31%-43.32%62.41%-44.31%63.92%-9.3%51.8%5.99%6.52%-4.44%16.95%33.27%180.32%72.3%-67.1%83.98%-16.82%-70.13%-10.44%10.16%15.43%93.9%58.08%63.35%-3.17%-50.6%0.27%-23.03%25.18%4.91%
EPS (Diluted)7.517.483.235.843.546.504.094.533.002.842.702.852.471.890.680.361.200.680.822.562.622.294.071.220.790.490.500.930.881.140.92
EPS Growth %99.18%131.58%-44.69%64.97%-45.54%58.92%-9.71%51%5.63%5.19%-5.26%15.38%30.69%177.94%88.89%-70%76.47%-17.07%-67.97%-2.29%14.41%-43.73%233.61%54.43%61.22%-2%-46.24%5.68%-22.81%23.91%2.22%
EPS (Basic)-7.483.255.873.576.554.114.573.002.892.742.902.521.910.690.371.230.690.842.802.972.742.371.260.810.520.530.990.941.210.96
Diluted Shares Outstanding60.5M61.1M61.3M60.97M60.88M60.67M60.29M60M59.71M59.36M58.75M58.16M57.35M56.81M55.93M55.22M54.5M53.53M53.32M57.16M62.54M64.71M64.76M54.29M53.24M52.85M53.14M57.75M60.82M61.32M60.77M

Key Metrics

Growth RegimeDecelerating
ProfitabilityModerate
Balance SheetVulnerable
Cash FlowMixed
Top Statement Risk

Social inflation and reserve volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Premium Growth Deceleration Amid Competition

According to quarterly financial data, Selective Insurance Group's revenue growth has decelerated from a peak of 16.6% in 2023Q4 to 5.7% in 2026Q1, suggesting that the company is facing increased competitive pressure or reaching saturation in its core mid-market commercial lines segment.

The consistent decline in year-over-year revenue growth rates indicates that the firm's ability to push rate increases may be waning as the market cycle shifts. Investors should monitor whether this deceleration reflects a strategic choice to prioritize underwriting discipline over volume or a loss of market share to more aggressive national carriers.

Underwriting Profitability Remains Generally Resilient

As reported in recent income statements, the company maintained a combined ratio of 89.9% in 2026Q1, demonstrating that Selective Insurance Group continues to generate a solid underwriting profit despite the significant volatility observed in the 2024Q2 period where the ratio spiked to 106.7%.

The return to sub-90% combined ratios suggests that the company's field-based underwriting model is effectively managing loss costs. However, the historical variance in these figures warrants caution, as it implies that the firm remains susceptible to periodic, sharp increases in loss severity that could quickly erode operating margins.

2024Q2 Loss Event Remains Outlier

Based on the provided historical figures, the 2024Q2 period represents a critical inflection point where the company reported a net loss of $63.3 million and a combined ratio of 106.7%, marking a temporary but severe departure from its otherwise consistent history of underwriting profitability.

This specific quarter highlights the inherent risk in the company's portfolio, likely driven by a combination of catastrophe events and potential reserve adjustments. While subsequent quarters show a recovery, this event serves as a reminder that the firm's earnings profile is not immune to significant, non-recurring underwriting shocks.

Capital Structure Discrepancies Demand Scrutiny

Financial statements reveal a highly unusual cash position of $346,000 and a debt-to-equity ratio of 0.25%, which, based on industry standards for a multi-billion dollar insurer, suggests either a reporting anomaly or a potential misunderstanding of the consolidated group's true liquidity and leverage profile.

These figures appear inconsistent with the capital requirements of a P&C carrier of this scale and warrant immediate verification against audited GAAP filings. Analysts should be wary of relying on these specific metrics until the company provides clarity on whether these represent the full scope of corporate liquidity.

SIGI — Frequently Asked Questions

Quick answers to the most common questions about buying SIGI stock.

What was Selective Insurance Group, Inc.'s (SIGI) revenue in 2025?

For fiscal year 2025, Selective Insurance Group, Inc. (SIGI) reported total revenue of $5.34B. This represents a 563.1% increase compared to $804.8M in 1996.

Is Selective Insurance Group, Inc. (SIGI) profitable?

Selective Insurance Group, Inc. (SIGI) is profitable, generating $466.4M in net income for the fiscal year ending 2025 with a net profit margin of 8.7%.

What is Selective Insurance Group, Inc.'s operating profit margin?

Selective Insurance Group, Inc. (SIGI) reported an operating income of $589.6M, resulting in an operating profit margin of 11.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Selective Insurance Group, Inc.'s gross profit and gross margin?

Selective Insurance Group, Inc. (SIGI) generated $2.18B in gross profit for the year, representing a gross profit margin of 40.9%. This demonstrates the company's core pricing power and production efficiency.